AFP and hepatocellular carcinoma: All three patients with clinically diagnosed HCC had elevated serum AFP levels at the time of detection (median, 141.6 ng/mL; range, 39.6–720.0), and these AFP levels declined to <20 ng/mL after the first treatment (median, 6.0 ng/mL; range, 4.1–9.7).